aTyr Pharma (http://www.atyrpharma.com) closed a Series C round of funding from a set of investors including Polaris Venture Partners, Cardinal Partners, Alta Partners and Domain Associates. The company is located in San Diego, California.
aTyr Pharma is discovering and developing biotherapeutics to treat a variety of diseases, including inflammation, autoimmune, hematopoietic and metabolic disorders.
This aTyr Pharma funding from Polaris Venture Partners, Cardinal Partners, Alta Partners and Domain Associates was detailed in FundingFlash – a comprehensive daily email detailing companies receiving venture capital, growth equity or angel investment funding.

October 17th, 2010
the Chubby Team
Posted in 